Importance of P450 reductase activity in breast tumour cells for determining sensitivity to the bioreductive drug, tirapazamine (SR 4233)

AA.V Patterson, H.G Barham, E Chinje, C. Adams, Harris A.L G.E., IJ. Stratford

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalBr. J. Cancer
    Volume72
    Publication statusPublished - 1995

    Cite this